Food Allergy Course logo

Food Allergy: From Primary Prevention to Treatment and Intervention Online

Now Available!


These recordings are of the live course held in Chicago September 6-8, 2019. Their intent is to allow learners to increase their knowledge related to the diagnosis and management of food allergic patients. It highlights  the latest evidence related to food allergies with a focus on preparing practitioners to provide optimal care to their food-allergic patients.


Fees
AAAAI Fellows/Members

$200.00

Non-members

$250.00

Nurses/Allied Health (Contact us for coupon code: cme@aaaai.org)

$100.00

Fellows-in-training (Contact us for coupon code: cme@aaaai.org)

$100.00


Target Audience

  • Practicing physicians (A/I specialists and others who treat food-allergic patients)
  • Fellows-in-training
  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Allied Health practitioners

 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply evidence-based decision making to the diagnosis of food allergic patients
  • Translate into practice the approved guidelines for food allergy prevention
  • Implement effective education strategies related to the prevention and treatment of anaphylaxis
  • Identify and apply the treatment options currently available for patients with food allergies

 


Summary
Available credit: 
  • 10.75 Attendance
    Attendance credit.
  • 10.75 CE
    CE credit.
  • 10.75 CME
    CME credit.
Course opens: 
07/17/2019
Course expires: 
10/31/2021
Member cost:
$200.00
Cost:
$250.00
Rating: 
0
Overview of Food Allergy Diagnosis and Management
Epidemiology & Natural History of Food Allergy w/ Q&A
Pathophysiology of Food Allergy w/ Q&A
Food Allergy Cases: Clinical Presentations of Food Allergy w/ Q&A
Food Allergy Cases: Approach to Diagnosis and Management w/ Q&A
Optimal Use Diagnostic Testing:  Components and Oral Food Challenges w/ Q&A
Anaphylaxis: Prevention and Management w/ Q&A
Panel Discussion
 
Overview of Specific Syndromes
Nuts and Bolts of Atopic Dermatitis w/ Q&A
Non IgE Mediated Food Allergy w/ Q&A
Eosinophilic Esophagitis: Optimal Diagnosis and Management w/ Q&A
 
Overview of the Treatment of Food Allergy
Oral Immunotherapy: Integration into Clinical Practice w/ Q&A
Epicutaneous Immunotherapy w/ Q&A
The Role of Omalizumab in Food Allergy w/ Q&A
Phase I and Phase II Clinical Trials Moving Through FDA Process w/ Q&A
Panel Discussion
 
Overview of Research & Prevention of Food Allergy
Prevention of Peanut Allergy w/ Q&A
Prevention of Food Allergy: Beyond Peanut w/ Q&A
Taking this course back to the clinic
Panel Discussion
Planning Committee

Robert Wood, MD FAAAAI
Johns Hopkins University School of Medicine, Baltimore, MD
Relevant relationships: Aimmune (research grant); Astellas (research grant); DBV Technologies (research grant); HAL-Allergy (research grant); Sanofi (research grant); Regeneron (research grant)

Ashley Devonshire, MD
Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
Relevant relationships: None

Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Lily Pien, MD FAAAAI
Cleveland Clinic Foundation, Cleveland, OH
Relevant relationships: None

Yamini Virkud, MD
Massachusetts General Hospital, Boston, MA
Relevant relationships: None

Speaking Faculty

Cecilia Berin, PhD
Mount Sinai School of Medicine, New York City, NY
Relevant relationships: TBD

J. Andrew Bird, MD FAAAAI
University of Texas Southwestern Medical Center, Dallas, TX
Relevant relationships: DBV Technologies (advisory board, speaker, research grant); Aimmune Therapeutics (advisory board); Pfizer (advisory board); Pharm Olam International (data & safety monitoring board)

Christina Ciaccio, MD FAAAAI
University of Chicago, Chicago, IL
Relevant relationships: Regeneron (advisory board); Aimmune (speaker)

David Fleischer, MD FAAAAI
University of Colorado Medicine/Children’s Hospital Colorado, Aurora, CO
Relevant relationships: Aquestive (consultant); INSYS Therapeutics, Inc. (consultant); AllerGenis (consultant); Nutricia (speaker); Abbott (speaker); Aimmune Therapeutics (research grant); DBV Technologies (consultant, advisory board, research grant)

Marion Groetch, MS RDN
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Nutricia North America (speaker); Mead Johnson (speaker); Abbott (speaker)

Anne Hiegel, APRN
University of Arkansas Medical School/Arkansas Children’s Hospital, Little Rock, AR
Relevant relationships: None

Jackie Isola, RN MS CPNP
Johns Hopkins Hospital, Baltimore, MD
Relevant relationships: None

Stacie Jones, MD
University of Arkansas Medical School/Arkansas Children’s Hospital, Little Rock, AR
Relevant relationships: Aimmune Therapeutics (advisory board, clinical trials); Sanofi, Inc. (clinical trials); DBV Technologies (clinical trials); Astellas, Inc. (clinical trials)

Corinne Keet, MD MS PhD
Johns Hopkins School of Medicine, Baltimore, MD
Relevant relationships: None

John Kelso, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None

Donald Leung, MD PhD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Abbvie (advisory board); Aimmune (advisory board); Incyte (advisory board); Novartis (advisory board); Regeneron (advisory board); Sanofi (advisory board); Pfizer (research grant)

Emily McGowan, MD PhD FAAAAI
University of Virginia School of Medicine, Charlottesville, VA
Relevant relationships: Shire (consultant)

Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Sally Noone, RN MSN
Retired
Relevant relationships: None

Anna Nowak-Wegrzyn, MD PhD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Merck (advisory board); Abbott (speaker); Mead Johnson (speaker); Gerber (advisory board); Alk Abello (clinical trials); Labcorp (advisory board); Astellas (research grant); DBV Technologies (research grant)

Wayne Shreffler, MD PhD FAAAAI
Massachusetts General Hospital, Boston, MA
Relevant relationships: None

Scott Sicherer, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: HAL Allergy (research grant)

Jonathan Spergel, MD PhD FAAAAI
Children’s Hospital of Philadelphia, Philadelphia, PA
Relevant relationships: DBV Technologies (advisory board); Regeneron (consultant)

Pamela Steele, MSN CPNP AE-C
University of North Carolina at Chapel Hill Health Care, Chapel Hill, NC
Relevant relationships: None

Carina Venter, PhD RD
University of Colorado/Children’s Hospital Colorado, Aurora, CO
Relevant relationships: Danone (speaker); Mead Johnson (speaker); Nestle (speaker); DBV Technologies (advisory board); Abbott (speaker); Thermo Fisher (research grant)

Brian Vickery, MD FAAAAI
Emory University, Atlanta, GA
Relevant relationships: Thermo Fisher (speaker); Aimmune (advisory board)

Julie Wang, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: JDP Therapeutics (advisory board); Aimmune (consultant); DBV Technologies (advisory board)

Robert Wood, MD FAAAAI
Johns Hopkins University School of Medicine, Baltimore, MD
Relevant relationships: Aimmune (research grant); Astellas (research grant); DBV Technologies (research grant); HAL-Allergy (research grant); Sanofi (research grant); Regeneron (research grant)

Content Reviewers

Anne Borgmeyer, RN CPNP AE-C
St. Louis Childrens Hospital, St. Louis, MO
Relevant relationships: None

Brian Kelly, MD
St. Paul Allergy and Asthma, St. Paul, MN
Relevant relationships: None


AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.



Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this [live activity or enduring material] for a maximum of 10.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 10.75 Contact Hours.


Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on MONTH, DAY YEAR. Requests to claim credit on or after July 1, 2020 will be denied.


AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.


Questions

All questions should be directed to cme@aaaai.org.

Available Credit

  • 10.75 Attendance
    Attendance credit.
  • 10.75 CE
    CE credit.
  • 10.75 CME
    CME credit.

Accreditation Period

Course opens: 
07/17/2019
Course expires: 
10/31/2021

Price

Member cost:
$200.00
Cost:
$250.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.